{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T13:12:34Z","timestamp":1765977154488,"version":"3.48.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,17]]},"DOI":"10.7759\/cureus.99452","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T13:09:08Z","timestamp":1765976948000},"source":"Crossref","is-referenced-by-count":0,"title":["Recanalization of the PRESERFLO MicroShunt With a 9-0 Nylon Suture: A Case Report"],"prefix":"10.7759","author":[{"given":"Mao","family":"Ishiyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Tatsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham YC","year":"2014","unstructured":"Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014, 121:2081-90. 10.1016\/j.ophtha.2014.05.013","journal-title":"Ophthalmology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/rb\/rbw005","article-title":"The use of poly(styrene-block-isobutylene-block-styrene) as a microshunt to treat glaucoma","volume":"3","author":"Pinchuk L","year":"2016","unstructured":"Pinchuk L, Riss I, Batlle JF, et al.. The use of poly(styrene-block-isobutylene-block-styrene) as a microshunt to treat glaucoma. Regen Biomater. 2016, 3:137-42. 10.1093\/rb\/rbw005","journal-title":"Regen Biomater"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.b.33525","article-title":"The development of a micro-shunt made from poly(styrene-block-isobutylene-block-styrene) to treat glaucoma","volume":"105","author":"Pinchuk L","year":"2017","unstructured":"Pinchuk L, Riss I, Batlle JF, et al.. The development of a micro-shunt made from poly(styrene-block-isobutylene-block-styrene) to treat glaucoma. J Biomed Mater Res B Appl Biomater. 2017, 105:211-21. 10.1002\/jbm.b.33525","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.10.13.26","article-title":"Evaluation of the ultrastructural and in vitro flow properties of the PRESERFLO MicroShunt","volume":"10","author":"Ibarz Barber\u00e1 M","year":"2021","unstructured":"Ibarz Barber\u00e1 M, Hern\u00e1ndez-Verdejo JL, Bragard J, et al.. Evaluation of the ultrastructural and in vitro flow properties of the PRESERFLO MicroShunt. Transl Vis Sci Technol. 2021, 10:26. 10.1167\/tvst.10.13.26","journal-title":"Transl Vis Sci Technol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogla.2021.07.008","article-title":"Safety and effectiveness of the PRESERFLO(R) MicroShunt in primary open-angle glaucoma: results from a 2-year multicenter study","volume":"5","author":"Beckers HJ","year":"2022","unstructured":"Beckers HJ, Aptel F, Webers CA, et al.. Safety and effectiveness of the PRESERFLO(R) MicroShunt in primary open-angle glaucoma: results from a 2-year multicenter study. Ophthalmol Glaucoma. 2022, 5:195-209. 10.1016\/j.ogla.2021.07.008","journal-title":"Ophthalmol Glaucoma"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogla.2021.08.005","article-title":"Effectiveness of MicroShunt in patients with primary open-angle and pseudoexfoliative glaucoma: a retrospective European multicenter study","volume":"5","author":"Fea AM","year":"2022","unstructured":"Fea AM, Laffi GL, Martini E, Economou MA, Caselgrandi P, Sacchi M, Au L. Effectiveness of MicroShunt in patients with primary open-angle and pseudoexfoliative glaucoma: a retrospective European multicenter study. Ophthalmol Glaucoma. 2022, 5:210-8. 10.1016\/j.ogla.2021.08.005","journal-title":"Ophthalmol Glaucoma"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-021-01811-w","article-title":"Efficacy and safety of PreserFlo((R)) MicroShunt after a failed trabeculectomy in eyes with primary open-angle glaucoma: a retrospective study","volume":"38","author":"Quaranta L","year":"2021","unstructured":"Quaranta L, Micheletti E, Carassa R, Bruttini C, Fausto R, Katsanos A, Riva I. Efficacy and safety of PreserFlo((R)) MicroShunt after a failed trabeculectomy in eyes with primary open-angle glaucoma: a retrospective study. Adv Ther. 2021, 38:4403-12. 10.1007\/s12325-021-01811-w","journal-title":"Adv Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0000000000001734","article-title":"Long-term results of the PRESERFLO MicroShunt in patients with primary open-angle glaucoma from a single-center nonrandomized study","volume":"30","author":"Batlle JF","year":"2021","unstructured":"Batlle JF, Corona A, Albuquerque R. Long-term results of the PRESERFLO MicroShunt in patients with primary open-angle glaucoma from a single-center nonrandomized study. J Glaucoma. 2021, 30:281-6. 10.1097\/IJG.0000000000001734","journal-title":"J Glaucoma"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-023-06075-4","article-title":"PRESERFLO \u2122 MicroShunt versus trabeculectomy: 1-year results on efficacy and safety","volume":"261","author":"Jamke M","year":"2023","unstructured":"Jamke M, Herber R, Haase MA, Jasper CS, Pillunat LE, Pillunat KR. PRESERFLO \u2122 MicroShunt versus trabeculectomy: 1-year results on efficacy and safety. Graefes Arch Clin Exp Ophthalmol. 2023, 261:2901-15. 10.1007\/s00417-023-06075-4","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-022-02734-y","article-title":"Effectiveness and cost-effectiveness of MicroShunt implantation versus standard trabeculectomy for open-angle glaucoma (a SIGHT study): study protocol of a multicentre randomised controlled trial","volume":"23","author":"Scheres LM","year":"2023","unstructured":"Scheres LM, van den Biggelaar FJ, Winkens B, et al.. Effectiveness and cost-effectiveness of MicroShunt implantation versus standard trabeculectomy for open-angle glaucoma (a SIGHT study): study protocol of a multicentre randomised controlled trial. BMC Ophthalmol. 2023, 23:43. 10.1186\/s12886-022-02734-y","journal-title":"BMC Ophthalmol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/aos.14968","article-title":"PRESERFLO\u2122 MicroShunt versus trabeculectomy: first results on efficacy and safety","volume":"100","author":"Pillunat KR","year":"2022","unstructured":"Pillunat KR, Herber R, Haase MA, Jamke M, Jasper CS, Pillunat LE. PRESERFLO\u2122 MicroShunt versus trabeculectomy: first results on efficacy and safety. Acta Ophthalmol. 2022, 100:e779-90. 10.1111\/aos.14968","journal-title":"Acta Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0000000000002049","article-title":"Iris obstruction following PRESERFLO MicroShunt implantation and surgical management","volume":"31","author":"Trigaux C","year":"2022","unstructured":"Trigaux C, Steindor FA, Spaniol K, Geerling G, Borrelli M. Iris obstruction following PRESERFLO MicroShunt implantation and surgical management. J Glaucoma. 2022, 31:e72-4. 10.1097\/IJG.0000000000002049","journal-title":"J Glaucoma"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2022.101347","article-title":"Conjunctival erosion following a PRESERFLO\u00ae MicroShunt procedure","volume":"25","author":"Fahy ET","year":"2022","unstructured":"Fahy ET, Ho H, Dukht U, Garg A, Lim KS. Conjunctival erosion following a PRESERFLO\u00ae MicroShunt procedure. Am J Ophthalmol Case Rep. 2022, 25:101347. 10.1016\/j.ajoc.2022.101347","journal-title":"Am J Ophthalmol Case Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.84799","article-title":"A case report of the combined use of neodymium-doped yttrium aluminum garnet and argon lasers in treating luminal obstruction by iris tissue in a Preserflo MicroShunt implant","volume":"17","author":"Tamil Chelvan T","year":"2025","unstructured":"Tamil Chelvan T, Yogesvaran R, Cheng TC, Che Hamzah J. A case report of the combined use of neodymium-doped yttrium aluminum garnet and argon lasers in treating luminal obstruction by iris tissue in a Preserflo MicroShunt implant. Cureus. 2025, 17:e84799. 10.7759\/cureus.84799","journal-title":"Cureus"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-023-03109-7","article-title":"Recanalization of Xen45 gel stent implant occlusion using 10\u2009-\u20090 nylon suture in refractory glaucoma: a case report","volume":"23","author":"Zhang Y","year":"2023","unstructured":"Zhang Y, Xiang H, Zhang Y, Tang L. Recanalization of Xen45 gel stent implant occlusion using 10\u2009-\u20090 nylon suture in refractory glaucoma: a case report. BMC Ophthalmol. 2023, 23:418. 10.1186\/s12886-023-03109-7","journal-title":"BMC Ophthalmol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s40123-019-0186-6","article-title":"Nd:YAG laser for Ahmed tube shunt blockage in patients implanted with Boston type I keratoprosthesis","volume":"8","author":"Gu J","year":"2019","unstructured":"Gu J, Zhang Y, Zhai J, Ou Z, Chen J. Nd:YAG laser for Ahmed tube shunt blockage in patients implanted with Boston type I keratoprosthesis. Ophthalmol Ther. 2019, 8:333-9. 10.1007\/s40123-019-0186-6","journal-title":"Ophthalmol Ther"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000026652","article-title":"Combined argon laser peripheral iridoplasty and Nd: YAG laser shock wave therapy for recurrent XEN gel stent obstruction due to iris incarceration. A case report","volume":"100","author":"Rho S","year":"2021","unstructured":"Rho S, Lim SH. Combined argon laser peripheral iridoplasty and Nd: YAG laser shock wave therapy for recurrent XEN gel stent obstruction due to iris incarceration. A case report. Medicine (Baltimore). 2021, 100:e26652. 10.1097\/MD.0000000000026652","journal-title":"Medicine (Baltimore)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0000000000001589","article-title":"Laser iridoplasty to treat iris-occluded XEN gel stent","volume":"29","author":"Tadrosse AF","year":"2020","unstructured":"Tadrosse AF, Khouri AS. Laser iridoplasty to treat iris-occluded XEN gel stent. J Glaucoma. 2020, 29:e91-2. 10.1097\/IJG.0000000000001589","journal-title":"J Glaucoma"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/446664-recanalization-of-the-preserflo-microshunt-with-a-9-0-nylon-suture-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T13:09:09Z","timestamp":1765976949000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/446664-recanalization-of-the-preserflo-microshunt-with-a-9-0-nylon-suture-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.99452","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,17]]}}}